Use of Melatonin in people with Parkinson’s disease - service improvement audit
Poster
Introduction
Sleep disturbance in PD is common approximately 70% affected.
Associated with poor quality of life
Types of sleep disturbance = restless legs, excessive daytime sleepiness REM sleep behaviour disorder
NICE guidance “Consider clonazepam or melatonin to treat RBD if a medicines review has addressed possible pharmacological causes” (NICE., 2017)
Melatonin has a significant role in the circadian rhythm regulatory function
Currently:
Melatonin is being used to treat sleep disorders in the Scarborough/Bridlington region
Subjectively reviewed at clinic visits without an objective measure
Allowed for community prescription in patient within the East Yorkshire CCG but not for the North Yorkshire region – all of which attend the same PD service coordinated by Scarborough Hospital
Objective
To evaluate use of melatonin in patients with PD and associated REM sleep behaviour disorder
To objectively quantify effect, allowing for cost analysis of use and standardise protocols for use over the region using PDSS.
To ensure every patient does a PDSS before and after starting melatonin
More Parkinson's Academy Sleep Projects
'The things you can't get from the books'
Parkinson's Academy, our original and longest running Academy, houses 20 years of inspirational projects, resources, and evidence for improving outcomes for people with Parkinson's. Led by co-founder and educational director Dr Peter Fletcher, the Academy has a truly collegiate feel and prides itself on delivering 'the things you can't get from books' - a practical learning model which inspires all Neurology Academy courses.